Información del producto
SAH-SOS1A is a peptidomimetic that has been shown to activate the pancreatic secretory response, in vitro assays, and cancer cell lines. Activation of the pancreatic secretory response by SAH-SOS1A has been shown to be due to its ability to inhibit the activity of effector proteins. It has been shown to have a higher potency than sapanisertib, which is an inhibitor of the sarcoma viral oncogene. Further research has shown that SAH-SOS1A is able to inhibit coagulation in human cancer cells, while also having no toxicity in normal human cells.
Propiedades químicas
Consulta técnica sobre: 3D-CRC56187 SAH-SOS1A
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.